Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Whole Genome Sequencing Detects Infection Transmission in NICU

By LabMedica International staff writers
Posted on 23 May 2024

A new study has shown that whole genome sequencing (WGS) of bacterial pathogens acquired from surveillance in a neonatal intensive care unit (NICU) can reveal significant infection transmission that goes undetected by standard infection control measures. More...

The research highlights that even in well-equipped medical facilities and in areas like the NICU where vigilant monitoring is routine, WGS provides a level of detection of transmission events that current methods cannot achieve.

Conducted by Next Gen Diagnostics (NGD, West Palm Beach, FL, USA) and researchers from Vanderbilt University Medical Center (VUMC, Nashville, TN, USA), the study analyzed 171 S. aureus samples from 132 individual patients. These samples were collected during routine surveillance in April, June, and July, and were supplemented with clinical samples. The samples were sequenced using short-read sequencing techniques and analyzed by NGD’s automated system to determine the relatedness of core genomes at the SNP level.

A stringent cutoff of 6 SNPs was used to identify potential transmission, which was then further assessed by the VUMC infection prevention team. The analysis found that 42 out of 132 patients (31.8%) with S. aureus infections were linked by transmission chains. Notably, the incidence of patients with MRSA infections connected by transmission was 46.8%, more than double the rate found in patients with MSSA infections, which stood at 21.2%. The study identified 13 distinct strains involved in these transmissions, indicating localized, undetected sources of spread rather than a ward-wide outbreak.

“We found that WGS of S. aureus isolates obtained from surveillance swabs and clinical samples revealed a significant amount of likely transmission, which provided guidance enabling our infection control team to take a series of actions with beneficial effect,” said Dr. Romney Humphries, Professor of Pathology, Microbiology and Immunology and Director of Laboratory Medicine at VUMC and senior author on the study.

“This result, along with those emerging from other medical centers, of the use of WGS to detect rather than simply verify transmission may signal a sea-change in best practice,” added Tom Talbot, Professor of Medicine and Medical Director of Infection Prevention at VUMC. “With a sufficiently low cost for sequencing and bioinformatic analysis, use of WGS to detect transmission, at least in those wards where patients are at the greatest risk, may become a more routine infection prevention practice.”

Related Links:
NGD
VUMC


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.